Members of the European Commission, the European Medicines Agency, and the US FDA held their 2020 bilateral regulatory meeting virtually from June 18–19, 2020. The agencies discussed ongoing joint initiatives and strategies for collaborating in the future.
The agencies, which have been collaborating since 2003 with daily interactions and working groups, have been working more closely amid the COVID-19 pandemic, specifically through the International Coalition of Medicines Regulatory Authorities.
